関連する実験動画
Updated: Feb 28, 2026

06:21
Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer
Published on: May 10, 2024
1.3K
[NAC‒イマチニブ後の胃GISTにおける表現型変化:症例報告]
Junki Yamada1, Kei Sato, Selen Tomita
1Dept. of Surgery, Yokohama City Minato Red Cross Hospital.
Gan to kagaku ryoho. Cancer & chemotherapy
|February 26, 2026
まとめ
本症例研究は、術前化学療法(NAC)後の消化管間質腫瘍(GIST)の診断上の課題を強調する。NAC後の組織病理学的所見は診断に影響を与え、正確な診断を困難にした。
科学分野:
- 消化器病学;腫瘍外科学;病理学
背景:
- 消化管間質腫瘍(GIST)は、消化管で最も一般的な間葉系腫瘍である。
- 術前化学療法(NAC)はGIST管理においてますます使用されているが、組織病理学的特徴への影響は十分に理解されていない。
- GISTの正確な診断は、特徴的な組織病理学的所見と免疫組織化学(IHC)染色に依存している。
研究 の 目的:
- NAC後のGIST診断における困難な症例を報告するため。
- NAC後のGISTにおけるIHC変化に関する文献をレビューするため。
- 組織病理学における治療後変化を考慮することの重要性を強調するため。
主な方法:
- 上腹部痛と粘膜下腫瘍を呈した53歳男性の症例提示。
- 胃内視鏡検査、生検、およびIHC(c-kit陽性)に基づいたGISTの初期診断。
- NAC後の外科的切除、それに続く摘出検体の詳細な組織病理学的分析。
主要な成果:
- 初期生検では紡錘形細胞増殖とc-kit陽性を示すGISTと診断された。;術後に摘出された検体の組織病理学的所見は、生検時の所見とは大きく異なっていた。;完全切除は達成されたが、術後の診断は組織学的な変化により複雑化した。
結論:
- 術前化学療法はGISTの組織病理学を著しく変化させ、診断上の課題をもたらす可能性がある。
- NAC後のGISTにおけるIHC変化に関する文献は乏しい。
- 本症例は、NAC後の検体の慎重な解釈の必要性と、治療誘発性の組織学的修飾に関するさらなる研究の必要性を強調するものである。
関連する概念動画
Gastritis III: Clinical Manifestations and Management
1.4K
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
1.4K
Gastritis-I: Introduction and Types
2.7K
Gastritis, defined by the inflammation or irritation of the stomach lining or gastric mucosa, manifests in several distinct forms: acute, chronic, reactive, and a specific subtype known as autoimmune metaplastic atrophic gastritis.
Acute gastritis presents as a sudden inflammation triggered by various stressors to the stomach lining, such as exposure to corrosive agents, local irritants like aspirin and other NSAIDs, alcohol consumption, radiation therapy, physical trauma, severe burns, sepsis,...
Acute gastritis presents as a sudden inflammation triggered by various stressors to the stomach lining, such as exposure to corrosive agents, local irritants like aspirin and other NSAIDs, alcohol consumption, radiation therapy, physical trauma, severe burns, sepsis,...
2.7K
Gastritis-II: Pathophysiology
1.5K
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
1.5K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
691
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
691
Barrett Esophagus-II: Clinical Manifestations and Management
1.3K
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
1.3K
Gastric Motility
3.6K
Gastric motility is the coordinated contraction and relaxation of stomach muscles that convert ingested food into chyme, a semi-liquid substance ready for further digestion in the intestines. The process begins with the vagus nerve inducing the relaxation of the smooth muscles in the fundus and body of the stomach, allowing these regions to expand and accommodate up to approximately 1.5 liters of food and liquid.
Peristaltic Waves and Chyme Formation
Upon food entry, the stomach initiates...
Peristaltic Waves and Chyme Formation
Upon food entry, the stomach initiates...
3.6K
